株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

PTCAバルーンカテーテルの世界市場:2015-2019年

Global PTCA Balloon Catheter Market 2015-2019

発行 TechNavio (Infiniti Research Ltd.) 商品コード 287784
出版日 ページ情報 英文 90 Pages
即納可能
価格
本日の銀行送金レート: 1USD=115.27円で換算しております。
Back to Top
PTCAバルーンカテーテルの世界市場:2015-2019年 Global PTCA Balloon Catheter Market 2015-2019
出版日: 2015年07月08日 ページ情報: 英文 90 Pages
概要

世界のPTCAバルーンカテーテルの市場は2014年から2019年にかけて3.48%のCAGRで成長すると予測されています。

当レポートでは、世界のPTCAバルーンカテーテルの市場について調査し、PTCA (経皮的冠動脈形成術) の概要、市場および製品の概要、市場全体および製品タイプ・地域別の市場分析および市場成長予測、市場成長への影響因子の分析、競合環境、主要企業のプロファイルなどをまとめています。

第1章 エグゼクティブサマリー

第2章 略語リスト

第3章 調査範囲

  • 市場概要
  • 主な製品

第4章 市場調査手法

  • 市場調査プロセス
  • 調査手法

第5章 イントロダクション

第6章 市場情勢

  • 市場概要
  • 市場規模・予測
  • ファイブフォース分析

第7章 PTCA:概要

  • PTCAについて
    • 背景
    • 定義
    • PTCAの段階
    • PTCAのメリット
    • PTCAの合併症とリスク
    • PTCA対象患者
  • PTCAバルーンカテーテル材料
    • 材料の比較
  • カテーテル法による合併症
    • 背景
    • 原因

第8章 製品タイプ別市場

  • 通常のバルーンカテーテル
  • 薬剤溶出型バルーンカテーテル
  • カッティングバルーンカテーテル
  • スコアリングバルーンカテーテル

第9章 地域分析

  • 南北アメリカ
    • 市場規模・予測
  • 欧州・中東・アフリカ
    • 市場規模・予測
  • アジア太平洋
    • 市場規模・予測

第10章 購入基準

第11章 市場成長因子

第12章 成長因子とその影響

第13章 市場の課題

第14章 成長因子と課題の影響

第15章 市場動向

第16章 動向とその影響

第17章 ベンダー情勢

  • 競合シナリオ
    • 主なニュース
    • M&A
  • 市場シェア分析
    • Abbott Laboratories
    • Boston Scientific
    • Medtronic
    • テルモ
  • その他の有望なベンダー

第18章 主要ベンダーの分析

  • Abbott Laboratories
  • Boston Scientific Corp.
  • Medtronic Inc.
  • テルモ

第19章 関連レポート

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: IRTNTR6427

About PTCA Balloon Catheter

PTCA is a minimally invasive procedure to open up blocked coronary arteries to permit unhindered blood flow to the heart muscle. In this procedure, catheters are positioned within the arteries to compress the plaques within a clogged coronary artery. A PTCA balloon catheter is a type of soft catheter equipped with a tiny inflatable balloon at its tip, which is inserted during a catheterization procedure into an artery that has been constricted by the addition of fatty deposits. The balloon is then bloated to clear the blockage and widen the artery. PTCA balloon catheters were the first devices used in the field of interventional cardiology. These catheters are also employed in the positioning of stents during angioplasty. PTCA balloon catheters are used in the PTCA procedures to compress the plaques within a blocked coronary artery.

Technavio's analysts forecast the global PTCA balloon catheter market to grow at a CAGR of 3.48% during 2014-2019.

Covered in this Report

The report includes the present scenario and the growth prospects of the global PTCA balloon catheter market for 2015-2019. The market can be segmented into four divisions: normal balloon catheter, drug eluting balloon catheter, cutting balloon catheter, and scoring balloon catheter. To calculate the market size, we consider the revenue generated from these PTCA balloon catheters.

Technavio's report, Global PTCA Balloon Catheter Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Abbott Laboratories
  • Boston Scientific
  • Medtronic
  • Terumo

Other Prominent Vendor

  • Aachen Resonance
  • Acrostak
  • Alvimedica
  • AngioScore
  • Arthesys
  • Asahi Intecc
  • Atrium Medical
  • B. Braun Melsungen
  • Biosensors International
  • BIOTRONIK
  • C.R. Bard
  • Cook Medical
  • Cordis
  • MicroPort Scientific
  • Natec Medical
  • Smiths Medical
  • Terumo Medical
  • Tokai Medical Products
  • Volcano

Market Driver

  • Growing Aging, Diabetic, and Obese Population
  • For a full, detailed list, view our report

Market Challenge

  • Availability of Alternative Therapies
  • For a full, detailed list, view our report

Market Trend

  • Increased Demand for Minimally Invasive Procedures
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. PTCA: An Overview

  • 07.1. About PTCA
    • 07.1.1. Background
    • 07.1.2. Definition
    • 07.1.3. Steps Involved in PTCA
    • 07.1.4. Advantages of PTCA
    • 07.1.5. Complications and Risks Involved in PTCA
    • 07.1.6. PTCA Balloon Catheters Affected Individuals
  • 07.2. PTCA Balloon Catheter Materials
    • 07.2.1. Comparison of Catheter Materials
  • 07.3. Complications of Catheterization
    • 07.3.1. Background
    • 07.3.2. Causes of Complications

08. Market Segmentation by Product Type

  • 08.1. Normal Balloon Catheter
  • 08.2. Drug Eluting Balloon Catheter
  • 08.3. Cutting Balloon Catheter
  • 08.4. Scoring Balloon Catheter

09. Geographical Segmentation

  • 09.1. PTCA Balloon Catheter Market in Americas
    • 09.1.1. Market Size and Forecast
  • 09.2. PTCA Balloon Catheter Market in EMEA
    • 09.2.1. Market Size and Forecast
  • 09.3. PTCA Balloon Catheter Market in APAC
    • 09.3.1. Market Size and Forecast

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and Their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Trends and Their Impact

17. Vendor Landscape

  • 17.1. Competitive Scenario
    • 17.1.1. Key News
    • 17.1.2. Mergers and Acquisitions
  • 17.2. Market Share Analysis 2014
    • 17.2.1. Abbott Laboratories
    • 17.2.2. Boston Scientific
    • 17.2.3. Medtronic
    • 17.2.4. Terumo
  • 17.3. Other Prominent Vendors

18. Key Vendor Analysis

  • 18.1. Abbott Laboratories Inc.
    • 18.1.1. Key Facts
    • 18.1.2. Business Description
    • 18.1.3. Business Segmentation
    • 18.1.4. Business Strategy
    • 18.1.5. Revenue by Business Segmentation
    • 18.1.6. Revenue Comparison 2011 and 2012
    • 18.1.7. Revenue by Geographical Segmentation
    • 18.1.8. Key Information
    • 18.1.9. SWOT Analysis
  • 18.2. Boston Scientific
    • 18.2.1. Key Facts
    • 18.2.2. Business Overview
    • 18.2.3. Key Products
    • 18.2.4. Key Products in Cardiovascular Segment
    • 18.2.5. Key Products in MedSurg Segment
    • 18.2.6. Key Products in Rhythm Management Segment
    • 18.2.7. Business Segmentation by Revenue 2013
    • 18.2.8. Business Segmentation by Revenue 2012 and 2013
    • 18.2.9. Geographical Segmentation by Revenue 2013
    • 18.2.10. Business Strategy
    • 18.2.11. Recent Developments
    • 18.2.12. SWOT Analysis
  • 18.3. Medtronic
    • 18.3.1. Key Facts
    • 18.3.2. Business Overview
    • 18.3.3. Key Products
    • 18.3.4. Business Segmentation by Revenue 2014
    • 18.3.5. Cardiac and Vascular Group Segmentation by Revenue 2014
    • 18.3.6. Restorative Therapies Group Segmentation by Revenue 2014
    • 18.3.7. Diabetes Group Segmentation by Revenue 2014
    • 18.3.8. Business Segmentation by Revenue 2013 and 2014
    • 18.3.9. Cardiac and Vascular Group Segmentation by Revenue 2013 and 2014
    • 18.3.10. Restorative Therapies Group Segmentation by Revenue 2013 and 2014
    • 18.3.11. Diabetes Group Segmentation by Revenue 2013 and 2014
    • 18.3.12. Geographical Segmentation by Revenue 2014
    • 18.3.13. Business Strategy
    • 18.3.14. Key Developments
    • 18.3.15. SWOT Analysis
  • 18.4. Terumo Corp.
    • 18.4.1. Key Facts
    • 18.4.2. Business Overview
    • 18.4.3. Business Segmentation
    • 18.4.4. Revenue Segmentation by Business
    • 18.4.5. Business Segment Revenue Comparison - FY2011 and FY2012
    • 18.4.6. Revenue Segmentation by Geography
    • 18.4.7. Business Strategy
    • 18.4.8. Key Developments
    • 18.4.9. SWOT Analysis

19. Other Reports in this Series

List Of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global PTCA Balloon Catheter Market 2014-2019 ($ millions)
  • Exhibit 3: Various Steps of PTCA
  • Exhibit 4: PTCA Balloon Catheter Materials
  • Exhibit 5: Common HAIs in Acute Care Settings
  • Exhibit 6: Major PTCA Balloon Catheter Complications
  • Exhibit 7: Segmentation of Global PTCA Balloon Catheter Market by Product Type
  • Exhibit 8: Segmentation of Global PTCA Balloon Catheter by Product Type 2014
  • Exhibit 9: Segmentation of Global PTCA Balloon Catheter Market by Geography 2014-2019
  • Exhibit 10: PTCA Balloon Catheter Market in Americas 2014-2019 ($ millions)
  • Exhibit 11: PTCA Balloon Catheter Market in EMEA 2014-2019 ($ millions)
  • Exhibit 12: PTCA Balloon Catheter Market in APAC 2014-2019 ($ millions)
  • Exhibit 13: Segmentation of Global PTCA Balloon Catheter Market by Geography 2014-2019
  • Exhibit 14: Segmentation of Global PTCA Balloon Catheter Market by Geography 2014-2019
  • Exhibit 15: Percentage of Elderly Aged Above 65 in Different Regions or Countries 2012 and 2050
  • Exhibit 16: Abbott Laboratories: Key Takeaways
  • Exhibit 17: Boston Scientific: Key Takeaways
  • Exhibit 18: Medtronic: Key Takeaways
  • Exhibit 19: Terumo: Key Takeaways
  • Exhibit 20: Abbott Laboratories Inc.: Business Segmentation
  • Exhibit 21: Abbott Laboratories Inc.: Revenue by Business Segmentation 2012
  • Exhibit 22: Abbott Laboratories Inc.: Revenue by Business Segmentation 2011 and 2012 ($ million)
  • Exhibit 23: Abbott Laboratories Inc.: Revenue by Geographical Segmentation 2012
  • Exhibit 24: Boston Scientific: Key Products in Cardiovascular Segment
  • Exhibit 25: Boston Scientific: Key Products in MedSurg Segment
  • Exhibit 26: Boston Scientific: Key Products in Rhythm Management Segment
  • Exhibit 27: Boston Scientific: Business Segmentation by Revenue 2013
  • Exhibit 28: Boston Scientific: Business Segmentation by Revenue 2012 and 2013 ($ million)
  • Exhibit 29: Boston Scientific: Geographical Segmentation by Revenue 2013
  • Exhibit 30: Medtronic: Key Products
  • Exhibit 31: Medtronic: Business Segmentation by Revenue 2014
  • Exhibit 32: Medtronic: Cardiac and Vascular Group Segmentation by Revenue 2014
  • Exhibit 33: Medtronic: Restorative Therapies Group Segmentation by Revenue 2014
  • Exhibit 34: Medtronic: Diabetes Group Segmentation by Revenue 2014
  • Exhibit 35: Medtronic: Business Segmentation by Revenue 2013 and 2014 ($ million)
  • Exhibit 36: Medtronic: Cardiac and Vascular Group Segmentation by Revenue 2013 and 2014 ($ million)
  • Exhibit 37: Medtronic: Restorative Therapies Group Segmentation by Revenue 2013 and 2014 ($ million)
  • Exhibit 38: Medtronic: Diabetes Group Segmentation by Revenue 2013 and 2014 ($ million)
  • Exhibit 39: Medtronic: Geographical Segmentation by Revenue 2014
  • Exhibit 40: Business Segmentation of Terumo Corp.
  • Exhibit 41: Revenue Segmentation of Terumo Corp.
  • Exhibit 42: Revenue Comparison of Business Segments ($ billion)
  • Exhibit 43: Revenue Segmentation by Geography FY2012
Back to Top